Erdal Tasci

Dr. Erdal Tasci

National Institutes of Health, Bethesda, Maryland, USA
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 June 2022 in Cancers
Verified
Journal Article
Open access
PDF file
ETErdal Tasci
Erdal Tasci
YZYing Zhuge
Ying Zhuge
Kevin A. CamphausenKevin A. Camphausen
Kevin A. Camphausen
AKAndra Valentina Krauze
Andra Valentina Krauze
Recent technological developments have led to an increase in the size and types of data in the medical field derived from multiple platforms such as proteomic, genomic, imaging, and clinical data. Many machine learning models have been developed to support precision/personalized medicine initiatives such as computer-aided detection, diagnosis, prognosis, and treatment planning by using large-scale medical data. Bias and class imbalance represent two of the most pressing challenges for machine learning-based problems, particularly in medical (e.g., oncologic) data sets, due to the limitations in patient numbers, cost, privacy, and security of data sharing, and the complexity of generated data. Depending on the data set and the research question, the methods applied to address class imbalance problems can provide more effective, successful, and meaningful results. This review discusses the essential strategies for addressing and mitigating the class imbalance problems for different medical data types in the oncologic domain.

1 May 2020 in Expert Systems with Applications
Verified
Journal Article
Closed access
OGOsman Gokalp
Osman Gokalp
ETErdal Tasci
Erdal Tasci
AUAybars UGUR
Aybars UGUR


Verified
Journal Article
Open access
PDF file
ETErdal Tasci
Erdal Tasci
YZYing Zhuge
Ying Zhuge
Harpreet KaurHarpreet Kaur
Harpreet Kaur
Kevin A. CamphausenKevin A. Camphausen
Kevin A. Camphausen
AKAndra Valentina Krauze
Andra Valentina Krauze
Determining the aggressiveness of gliomas, termed grading, is a critical step toward treatment optimization to increase the survival rate and decrease treatment toxicity for patients. Streamlined grading using molecular information has the potential to facilitate decision making in the clinic and aid in treatment planning. In recent years, molecular markers have increasingly gained importance in the classification of tumors. In this study, we propose a novel hierarchical voting-based methodology for improving the performance results of the feature selection stage and machine learning models for glioma grading with clinical and molecular predictors. To identify the best scheme for the given soft-voting-based ensemble learning model selections, we utilized publicly available TCGA and CGGA datasets and employed four dimensionality reduction methods to carry out a voting-based ensemble feature selection and five supervised models, with a total of sixteen combination sets. We also compared our proposed feature selection method with the LASSO feature selection method in isolation. The computational results indicate that the proposed method achieves 87.606% and 79.668% accuracy rates on TCGA and CGGA datasets, respectively, outperforming the LASSO feature selection method.

3 March 2015 in Journal of Medical Systems
Verified
Journal Article
Closed access
PDF file
ETErdal Tasci
Erdal Tasci
AUAybars UGUR
Aybars UGUR

15 August 2020 in Multimedia Tools and Applications
Verified
Journal Article
Closed access
PDF file
ETErdal Tasci
Erdal Tasci